Sign in
4

Changes in Ownership

TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-19-017232

Options or other derivatives

  • EVP, Chief Financial Officer acquired 50,746 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

McClellan Michael James · EVP, Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-04 Grant or award : show line 1 in the form Restricted Share Units +50,746 50,746 D
Loading xslF345X03/doc4.xml…